GlassScriptPhysician profile
Ernest B Brandt
NPI 1235523234
$21,011.68
in general payments reported to CMS, 2019-2025
45 companies · $5,594 in 2025
The $5,594 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,267 · 2022: $3,675 · 2023: $4,822 · 2024: $4,653 · 2025: $5,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,236.06 |
| Travel and Lodging | $833.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,014.94 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,545.81 | 2021-2025 | Farxiga, Wainua, Andexxa |
| Alnylam Pharmaceuticals INC. | $1,443.44 | 2021-2025 | Amvuttra, Onpattro |
| Amgen INC. | $1,429.20 | 2021-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,310.86 | 2021-2025 | Jardiance |
| Cvrx, INC. | $1,233.51 | 2024-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $1,129.96 | 2021-2025 | Camzyos, Eliquis |
| Pfizer INC. | $1,065.05 | 2021-2025 | |
| Abbott Laboratories | $1,027.97 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Aveir |
| Janssen Pharmaceuticals, INC | $925.15 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $807.12 | 2021-2025 | Watchman Flx, Watchman Access System, Watchman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $710.85 | 2021-2025 | Lifevest |
| Novo Nordisk INC | $695.60 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Merck Sharp & Dohme LLC | $647.94 | 2021-2025 | Verquvo, Capvaxive |
| Lexicon Pharmaceuticals, INC. | $608.87 | 2023-2024 | Inpefa |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $365.71 | 2023-2025 | |
| Philips North America LLC | $360.29 | 2022-2025 | (Ck4) Mcot, Ecc Solutions, (5044) Mcot |
| Actelion Pharmaceuticals US, INC. | $341.32 | 2022-2025 | Opsumit, Uptravi |
| Medtronic, INC. | $328.17 | 2022-2025 | Aurora Ev-Icd Mri Surescan, Linq II, Cobalt Dr Mri Surescan |
| Kestra Medical Technology Services, INC. | $321.45 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $291.98 | 2021-2025 | |
| Shockwave Medical, INC | $280.94 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Atricure, INC. | $268.10 | 2022-2023 | |
| Abiomed | $211.86 | 2023-2024 | Impella |
| Esperion Therapeutics, INC. | $186.09 | 2021-2022 | |
| Inari Medical, INC. | $158.06 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Regeneron Healthcare Solutions, INC. | $154.31 | 2021-2024 | Evkeeza, Praluent |
| Stryker Corporation | $143.59 | 2025 | Flowtriever |
| Daiichi Sankyo INC. | $141.41 | 2021-2024 | Injectafer |
| Sanofi-Aventis U.S. LLC | $129.57 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $96.47 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $95.69 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $81.39 | 2023 | Edarbyclor |
| United Therapeutics Corporation | $66.22 | 2021 | |
| Chiesi USA, INC. | $63.86 | 2025 | Juxtapid |
| Arbor Pharmaceuticals, INC. | $58.44 | 2021 | |
| Bridgebio Pharma, INC. | $49.73 | 2025 | Attruby |
| Janssen Scientific Affairs, LLC | $48.14 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $44.70 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $40.91 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $25.25 | 2021 | |
| Lantheus Medical Imaging, INC. | $22.44 | 2022 | |
| Irhythm Technologies, INC. | $17.89 | 2024 | Zio Xt Patch, Zio Monitor |
| Alexion Pharmaceuticals, INC. | $13.93 | 2022 | |
| Zoll Respicardia, INC. | $7.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Brandt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.